RSS Feeds
Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function
- Liesbeth Bax, MD, PhD;
- Arend-Jan J. Woittiez, MD, PhD;
- Hans J. Kouwenberg, MD;
- Willem P.T.M. Mali, MD, PhD;
- Erik Buskens, MD, PhD;
- Frederik J.A. Beek, MD, PhD;
- Branko Braam, MD, PhD;
- Frans T.M. Huysmans, MD, PhD;
- Leo J. Schultze Kool, MD, PhD;
- Matthieu J.C.M. Rutten, MD;
- Cornelius J. Doorenbos, MD, PhD;
- Johannes C.N.M. Aarts, MD;
- Ton J. Rabelink, MD, PhD;
- Pierre-François Plouin, MD;
- Alain Raynaud, MD;
- Gert A. van Montfrans, MD, PhD;
- Jim A. Reekers, MD, PhD;
- Anton H. van den Meiracker, MD, PhD;
- Peter M.T. Pattynama, MD, PhD;
- Peter J.G. van de Ven, MD, PhD;
- Dammis Vroegindeweij, MD, PhD;
- Abraham A. Kroon, MD, PhD;
- Michiel W. de Haan, MD, PhD;
- Cornelis T. Postma, MD, PhD; and
- Jaap J. Beutler, MD, PhD*
- From University Medical Center Utrecht and Julius Center for Health Sciences and Primary Care, Utrecht, Twenteborg Hospital Almelo, Almelo, University Medical Center Groningen, Groningen, University Medical Center Nijmegen, Nijmegen, Jeroen Bosch Hospital, 's-Hertogenbosch, Deventer Hospital, Deventer, University Medical Center Leiden, Leiden, Academic Medical Center Amsterdam, Amsterdam, Erasmus Medical Center Rotterdam and Maasstad Hospital, Rotterdam, and University Hospital Maastricht, Maastricht, the Netherlands; University of Alberta Hospital, Edmonton, Alberta, Canada; and European Hospital Georges Pompidou, Paris, France.
-
Figure 1. Study flow diagram.* Included in analysis.
-
Figure 2. Survival curves for the primary end point (top) and the primary end point plus death (bottom) during 2 years of follow-up.The analysis was censored by death and loss to follow-up.
Related Clinical Content
